Drug intelligence / Profile preview

Xinmai Kang capsule

Development stage
Unknown
Lead developer
First Affiliated Hospital of Guangxi University of Chinese Medicine
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Xinmai Kang capsule is a Traditional Chinese Medicine (TCM) formulation developed by The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine. It is primarily indicated for the treatment of stable exertional angina pectoris associated with coronary artery disease. In TCM theory, the capsule is designed to address patterns of qi stagnation, blood stasis, and phlegm obstruction. The drug has been evaluated in Phase II randomized, double-blind, parallel-group clinical trials in China, where its efficacy and safety were compared against placebo and the active control Linaoxin tablet.

Brand names
Xinmai Kang capsule
Other names
Xinmai Kang Jiaonang

Beyond the preview

Go deeper on Xinmai Kang capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinmai Kang capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call